Biomerica Inc [BMRA] stock prices are up 6.50% to $0.36 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BMRA shares have gain 14.84% over the last week, with a monthly amount drifted -2.63%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biomerica Inc [NASDAQ: BMRA] stock has seen the most recent analyst activity on November 10, 2020, when Colliers Securities initiated its Buy rating and assigned the stock a price target of $13. Previously, B. Riley FBR Inc. started tracking the stock with Buy rating on January 04, 2018, and set its price target to $7.50.
The stock price of Biomerica Inc [BMRA] has been fluctuating between $0.24 and $1.35 over the past year. Biomerica Inc [NASDAQ: BMRA] shares were valued at $0.36 at the most recent close of the market.
Analyzing the BMRA fundamentals
The Biomerica Inc [NASDAQ:BMRA] reported sales of 5.51M for trailing twelve months, representing a surge of 5.49%. Gross Profit Margin for this corporation currently stands at 0.09% with Operating Profit Margin at -1.18%, Pretax Profit Margin comes in at -1.11%, and Net Profit Margin reading is -1.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.78, Equity is -0.85 and Total Capital is -1.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3312 points at the first support level, and at 0.3001 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4022, and for the 2nd resistance point, it is at 0.4421.
Ratios To Look Out For
It’s worth pointing out that Biomerica Inc [NASDAQ:BMRA]’s Current Ratio is 3.00. In addition, the Quick Ratio stands at 2.09 and the Cash Ratio stands at 1.31. Considering the valuation of this stock, the price to sales ratio is 1.24, the price to book ratio is 1.14.
